HomeInsights52 Week Low Stocks

Shilpa Medicare Ltd 52 Week Low

Shilpa Medicare Ltd 52 Week Low

stocks purchased

₹ 0.4 Cr

Volume transacted

stocks purchased

4.5 K

stocks traded

Last Updated time: 05 Nov 14:08 PM

Image

Shilpa Medicare Ltd

NSE: SHILPAMED

YEARLOW

313.55

Last updated on: Nov 04, 2024

Key Highlights

  • The 52 Week Low of Shilpa Medicare Ltd is ₹ 313.55 as of 04 Nov 24.

Company Fundamentals for Shilpa Medicare Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Shilpa Medicare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 2024818.6
01 Nov 2024842.3
31 Oct 2024842.35
30 Oct 2024843.1
29 Oct 2024799.95
28 Oct 2024804.25
25 Oct 2024783.25
24 Oct 2024800.85
23 Oct 2024812.8
22 Oct 2024794.55

Asset Value vs Market Value of Shilpa Medicare Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical Net Profit of Shilpa Medicare Ltd

No data available

* All values are in crore

Shilpa Medicare Ltd News Hub

News

Shilpa Medicare schedules board meeting

Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 13 Novembe...

Read more

04 Nov 202418:42

News

Shilpa Medicare slips after US FDA issues four form 483 obersvations to Bengaluru facility

In a regulatory filing made during market hours today, the company informed the company's ...

Read more

31 Oct 202413:43

News

Shilpa Medicare arm gets CEP from EDQM for Desmopressin

Desmopressin is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid...

Read more

04 Oct 202408:40

News

Shilpa Medicare announces receipt of CEP from EDQM for API 'Desmopressin'

Shilpa Medicare's 100% subsidiary, Shilpa Pharma Lifesciences received certificate of suit...

Read more

03 Oct 202417:12

News

Shilpa Medicare arm appoints Sridevi Khambhampaty as CEO

Sridevi Khambhampaty y is a recognized leader in the Biologics industry with over two deca...

Read more

19 Sep 202413:35

News

Shilpa Biologicals appoints CEO

Shilpa Medicare announced the appointment of Dr. Sridevi Khambhampaty, as Chief Executive ...

Read more

19 Sep 202413:35

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week Low of Shilpa Medicare Ltd

Why is it important to track the 52-week low of Shilpa Medicare Ltd stocks?

Investors should monitor the 52-week low of Shilpa Medicare Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Shilpa Medicare Ltd stocks hitting a 52-week low?

Factors leading to Shilpa Medicare Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Shilpa Medicare Ltd stocks when they hit a 52-week low?

Buying Shilpa Medicare Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Shilpa Medicare Ltd stocks?

Investors should monitor the 52-week low of Shilpa Medicare Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Shilpa Medicare Ltd stock at their 52-week low?

An investor can analyze the reasons for the Shilpa Medicare Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Shilpa Medicare Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Shilpa Medicare Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Shilpa Medicare Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*